3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES. (2024). International Journal of Experimental Biology, 2(01), 50-73. https://ijeb.online/index.php/IJEB/article/view/23